0001193125-26-082233
SEC filingPrimerica, Inc. reported strong financial results for fiscal year 2025, with total revenues of $3.29 billion and net income of $751.2 million. The company's performance was driven by growth in net premiums, which increased to $1.78 billion from $1.73 billion in 2024, and commissions and fees, which rose to $1.28 billion from $1.08 billion. Net investment income contributed $167.2 million. The company generated $901.2 million in operating cash flow and returned significant capital to shareholders through $136.1 million in dividends and $450.0 million in common stock repurchases. Total assets stood at $15.01 billion, with stockholders' equity of $2.45 billion. The results reflect continued strength in the Term Life Insurance and Investment and Savings Products segments.
Primerica, Inc. delivered solid financial performance in fiscal year 2025, with total revenues of $3.29 billion, representing a 6.6% increase from $3.09 billion in 2024. Net income showed significant improvement to $751.2 million, up 59.7% from $470.5 million in the prior year. The company's earnings per share (EPS) strengthened substantially, with basic EPS reaching $23.00 compared to $13.73 in 2024. This performance was achieved despite a loss from discontinued operations of $249.6 million in 2024, which did not recur in 2025. The company's operating margin was 29.6%, reflecting efficient operations and strong segment performance.
Revenue growth was driven by multiple factors across the company's business segments. Net premiums increased to $1.78 billion from $1.73 billion in 2024, while commissions and fees grew significantly to $1.28 billion from $1.08 billion. Net investment income contributed $167.2 million, up from $155.5 million in the prior year. The Term Life Insurance segment generated $1.82 billion in revenues, up 2.9% year-over-year, while the Investment and Savings Products segment showed strong growth of 18.1% to $1.25 billion. The Corporate and Other Distributed Products segment declined 15.3% to $223.7 million. Geographically, the United States accounted for $2.85 billion of revenues, while Canada contributed $440.8 million.
The company maintained strong profitability metrics with income from continuing operations before income taxes of $974.6 million, up from $939.2 million in 2024. The operating margin of 29.6% reflects efficient cost management despite increases in key expense categories. Total benefits and expenses were $2.32 billion, including benefits and claims of $665.9 million, sales commissions of $686.9 million, and amortization of deferred policy acquisition costs of $322.9 million. The company's effective tax rate from continuing operations was 22.9%, slightly lower than the 23.3% rate in 2024. Segment profitability showed strength in the core businesses, with Term Life Insurance generating $621.1 million in income before taxes and Investment and Savings Products contributing $355.5 million.
Cash flow generation remained robust, with net cash provided by operating activities of $901.2 million. Free cash flow, calculated as operating cash flow less purchases of property and equipment, was $665.6 million. The company deployed capital through investing activities that used $235.6 million, primarily for available-for-sale investments, and financing activities that used $599.6 million, mainly for dividends and share repurchases. The balance sheet remained strong with total assets of $15.01 billion, including investments of $4.54 billion and cash and cash equivalents of $756.2 million. Total liabilities were $12.57 billion, with future policy benefits of $6.82 billion being the largest component. Stockholders' equity increased to $2.45 billion from $2.26 billion in 2024.
The filing indicates that the company continues to focus on its core business segments while managing risks associated with its operations. Key risk factors mentioned include the sensitivity of results to actuarial assumptions for future policy benefits, credit risk from reinsurance recoverables, and market risks affecting investment performance. The company's strategic priorities appear centered on maintaining growth in its Term Life Insurance and Investment and Savings Products segments while managing corporate expenses. The disposal of the Senior Health business in 2024 represents a strategic shift that has simplified the company's operations. Management's discussion highlights the importance of monitoring emerging experience against actuarial assumptions and maintaining strong capital positions in both U.S. and Canadian insurance subsidiaries.